SCHEMBL7531101

SCHEMBL7531101

NC(=O)C(N)c1cc(Cl)cc(C(=O)c2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.48
CNR1 P21554 1/20 0.48
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
PTGS1 P23219 2/20 0.42
CXCR1 P25024 2/20 0.42
CXCR2 P25025 2/20 0.42
PTGS2 P35354 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
RECQL P46063 1/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
PMP22 Q01453 1/20 0.42
SLC22A6 Q4U2R8 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11731205 0.89 CNR2 (0.49) CNR2CNR1MEN1KMT2AALDH1A1
Water SCHEMBL11468778 0.88 CNR2 (0.48) CNR2CNR1MEN1KMT2AALDH1A1
SCHEMBL11223031 0.83 CNR2 (0.43) CNR2CNR1MEN1KMT2AALDH1A1
SCHEMBL3146429 0.81 MAPT (0.58) MEN1KMT2AALDH1A1MAPTPTGS1
SCHEMBL11223033 0.80 CNR2 (0.43) CNR2CNR1MEN1KMT2AALDH1A1
SCHEMBL94130 0.79 SMN1; SMN2 (0.45) MEN1KMT2AALDH1A1MAPTPTGS1
SCHEMBL28157831 0.78 ATM (0.67) CNR2CNR1MEN1KMT2AALDH1A1
SCHEMBL9541835 0.78 CNR2 (0.70) CNR2CNR1MEN1KMT2AALDH1A1
SCHEMBL1353575 0.72 PARP1 (0.50) MEN1KMT2ACYP3A4PARP1TRPM8
SCHEMBL1353577 0.72 PARP1 (0.50) MEN1KMT2ACYP3A4PARP1TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0716600-B1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LAB INC (US) 2002-04-03 EP claimed
EP-0716600-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1996-06-19 EP claimed
WO-1995033457-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1995-12-14 WO claimed
US-5475034-A Adminstering 3-benzoylphenylacetamide derivatives ALCON LABORATORIES, INC. (US) 1995-12-12 US claimed
US-4313949-A Method of producing an inhibitory effect on blood platelet aggregation A. H. ROBINS COMPANY, INC. (US) 1982-02-02 US claimed
EP-0716600-B1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LAB INC (US) 2002-04-03 EP disclosed
EP-0716600-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1996-06-19 EP disclosed
WO-1995033457-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1995-12-14 WO disclosed
US-5475034-A Adminstering 3-benzoylphenylacetamide derivatives ALCON LABORATORIES, INC. (US) 1995-12-12 US disclosed
US-4313949-A Method of producing an inhibitory effect on blood platelet aggregation A. H. ROBINS COMPANY, INC. (US) 1982-02-02 US disclosed